trending Market Intelligence /marketintelligence/en/news-insights/trending/clxvb2ecqfvtw-o0s9byiq2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Green Organic Dutchman seeks to raise C$75M via bought-deal offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Green Organic Dutchman seeks to raise C$75M via bought-deal offering

The Green Organic Dutchman Holdings Ltd. will sell 10,950,000 units at C$6.85 apiece to a syndicate of underwriters for gross proceeds of about C$75 million.

Each unit in the offering comprises 1 common share and one warrant to purchase a common share of the company. Each warrant can be exercised at a price of C$9 for a period of 30 months from the closing date of the offering.

Underwriters for the offering have an overallotment option to buy up to an additional 1,642,500 units at the offering price. Canaccord Genuity Corp. is leading the syndicate of underwriters, which will buy the units on a bought-deal basis.

The Toronto-based pharmaceutical company said the net proceeds of the offering will be used for international expansion initiatives and general corporate purposes.

The offering is expected to close Oct. 17, subject to certain conditions, including receipt of all applicable regulatory approvals.